Barely Significant
← all excerpts

Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.

Sci Rep · 2017 · PMC5286400 · PMID 28145499

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

highly significantP < 0.05actually significant
The observed effects were highly significant (P < 0.05, control or EGCG vs . non-targeted and targeted NPs) in LNCaP, DU-145, and PC3 cells, suggesting that this behavior is general and not cell type specific.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.